Hangzhou Alltest Biotech Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Fei Gao
Chief executive officer
CN¥1.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 27.4% |
| Management average tenure | no data |
| Board average tenure | 1.1yrs |
Recent management updates
Recent updates
Hangzhou Alltest Biotech (SHSE:688606) May Have Issues Allocating Its Capital
Nov 22
Revenues Not Telling The Story For Hangzhou Alltest Biotech Co., Ltd. (SHSE:688606) After Shares Rise 27%
Oct 01Lacklustre Performance Is Driving Hangzhou Alltest Biotech Co., Ltd.'s (SHSE:688606) Low P/E
Aug 01Here's What's Concerning About Hangzhou Alltest Biotech's (SHSE:688606) Returns On Capital
Jun 08There Are Some Holes In Hangzhou Alltest Biotech's (SHSE:688606) Solid Earnings Release
May 03Optimistic Investors Push Hangzhou Alltest Biotech Co., Ltd. (SHSE:688606) Shares Up 27% But Growth Is Lacking
Apr 25CEO
Fei Gao (50 yo)
no data
Tenure
CN¥1,011,800
Compensation
Mr. Gao Fei serves as Chairman of the Board and General Manager at Hangzhou Alltest Biotech Co., Ltd.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥1.01m | 27.38% CN¥ 1.3b | |
| Deputy GM & Director | no data | CN¥803.30k | 3.36% CN¥ 162.8m | |
| Independent Director | 1.1yrs | no data | no data | |
| Chairman of the Supervisory Board | 1.1yrs | no data | 0.038% CN¥ 1.8m | |
| Director | no data | no data | no data | |
| Supervisor | 1.1yrs | no data | no data |
1.1yrs
Average Tenure
50yo
Average Age
Experienced Board: 688606's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 10:55 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hangzhou Alltest Biotech Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|